Hyperfine, Inc. (HYPR)
NASDAQ: HYPR · Real-Time Price · USD
0.7742
-0.0270 (-3.37%)
At close: Sep 16, 2026, 4:00 PM EDT
0.782637
+0.0084 (1.09%)
After-hours: Sep 16, 2026, 4:59 PM EDT
Hyperfine Revenue
Hyperfine had revenue of $3.90M in the quarter ending June 30, 2026, with 44.81% growth. This brings the company's revenue in the last twelve months to $16.54M, up 53.16% year-over-year. In the year 2025, Hyperfine had annual revenue of $13.56M with 5.22% growth.
Revenue (ttm)
$16.54M
Revenue Growth
+53.16%
P/S Ratio
5.14
Revenue / Employee
$162,127
Employees
102
Market Cap
82.10M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 13.56M | 673.00K | 5.22% |
| Dec 31, 2024 | 12.89M | 1.86M | 16.84% |
| Dec 31, 2023 | 11.03M | 4.22M | 61.90% |
| Dec 31, 2022 | 6.81M | 5.32M | 355.48% |
| Dec 31, 2021 | 1.50M | 1.20M | 408.84% |
| Dec 31, 2020 | 294.00K | - | - |
| Dec 31, 2019 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Outset Medical | 117.80M |
| Pulmonx | 87.44M |
| CVRx, Inc. | 61.19M |
| LENSAR | 60.26M |
| Apyx Medical | 58.42M |
| electroCore | 36.97M |
| Rapid Micro Biosystems | 35.18M |
| MaxCyte | 31.05M |
HYPR News
- 12 hours ago - MedtechWOMEN Names Hyperfine CEO Maria Sainz Winner of 2026 Ferolyn Powell Leadership Award - Business Wire
- 1 day ago - Hyperfine completes enrollment of Contrast PMR study - TheFly
- 1 day ago - Hyperfine Announces Completion of Enrollment in the Contrast PMR Study to Support the Submission to Expand Indications for Use of the Swoop® System with Contrast Agents - Business Wire
- 6 days ago - Hyperfine management to meet virtually with BTIG - TheFly
- 16 days ago - Hyperfine, Inc. to Participate in Lake Street Capital Markets 10th Annual Best Ideas Growth Conference - Business Wire
- 21 days ago - Hyperfine announces peer reviewed publication of NEURO PMR study - TheFly
- 21 days ago - Hyperfine Builds Momentum in Year One of Neurology Office Launch with NEURO PMR Publication and More Than 3,000 Scans - Business Wire
- 27 days ago - Hyperfine announces FDA clearance of Optive AI software update - TheFly